H5N1 influenza vaccine (Vaxine/Lovelace Respiratory Research Institute)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameH5N1 influenza vaccine (Vaxine/Lovelace Respiratory Research Institute)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesVaxine Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLovelace Respiratory Research InstituteVaxine Pty Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A